VCCircle Healthcare Investment Summit & Awards 2015

Introduction

Agenda

Speakers

Venue

Sponsors

Partners

Registration

Advancing, optimising and improving the quality of healthcare products & services is at the helm for any given healthcare professional in the country. The positive tailwinds of innovations, increasing awareness about quality healthcare, aging demographics & the rise of chronic conditions, favourable policy changes and growing demand for cost -effective local healthcare is certainly keeping the interest alive across the healthcare sector. To add, the spurge in med-tech & digital health is seen to be addressing both current as well as emerging challenges faced by traditionally run healthcare companies. Private investors, as witnessed in the past, are keeping a close watch on sector to spot emerging opportunities in asset light healthcare delivery models, technology plays besides itching for much awaited exits in the asset heavy healthcare delivery models.

To join the optimism, we are seeing a flurry of medico-entrepreneurs throwing in their hat to create world-class healthcare products & delivery systems in India by aligning with the entrepreneurial ecosystem in healthcare fraternity.After an overwhelming response from past six editions, VCCircle is pleased to announce the 7th edition of VCCircle Healthcare Investment Summit 2015, arguably India’s largest healthcare investment focused summit.

VCCircle Healthcare Awards
Besides, on the evening of September 15 we will be hosting the 3rd edition of VCCircle Healthcare Awards aiming at recognizing and rewarding outstanding healthcare providers who have not just made real differences in the patient’s life but have also created a culture of innovations & excellence across the Indian healthcare industry.

Day I, 15th September

8:30am - 9:30amTea, Networking & Registration

9:30am - 9:50amIntroductory Note

9:50am - 10:40amPanel I: Experiences of Catalysing growth through investor capital - myth vs reality
Riding on the back of growing demand for quality healthcare, rising disposable income chasing quality of life & health conscious users, healthcare sector in India has seen a lot of changes in the past five years. Most of the innovations & growth achieved in the sector has been fuelled by private investors banking on traditional as well as emerging healthcare business models. While the sector is opening doors for numerous opportunities and is now poised to show some exits with a chain of IPOs lined up showing some ray of hope to the private investors, we understand what has been the experience for private investors in real terms. Has the sector been able to deliver the promised returns or there is still time before they start expecting returns? Talking about future investments, which categories are set to draw significant amount of fund infusion? Which sub-segments within healthcare spectrum are experiencing notable activities?

10:40am - 11:30amPanel II: Will Consolidation drive the asset heavy healthcare models?
In quest of gaining market shares and capturing regional opportunities, many healthcare service providers are pursing consolidation strategies either to strengthen their position as market leaders or to reduce pressures on depleting balance sheets. With emergence on asset light models, there is an inherent pressure of asset heavy models and hence some movement is seen there. Will consolidation be seen in the asset heavy healthcare models? Is it the growth potential for premium quality healthcare services, demand -supply mismatch or under-penetrated healthcare services in the Tier II & III cities? Are private investors still banking on asset heavy models and coming in such acquisition transactions?

12:00pm - 12:50pmPanel III: Pharma opportunities in India - OTC, Drug Discovery & more
Pharma opportunity in India has been interesting in the recent past, ranging from large strategic M&A deals to emerging small cap pharma companies, focus on alternate medicine such as ayurveda, contract manufacturing of API besides others. Emergence of organized healthcare chains has opened up new avenues for pharma companies to serve the organized demand. Going with the recent changes in the pharma industry dynamics and inherent deep involvement of the government, what are the painful experiences faced by Indian pharma companies? How are the companies tacking with the growing issues of price controls, patent protection, structural, logistics & governance? What are the opportunities & challenges for MNC's stationed in India vis-a-vis domestic companies in terms of drug discovery models, patent rights, IPR, research cost, price barriers and regulatory approvals? Can India emerge as a market of "product differentiation" vis -a vis other emerging markets like China, Brazil etc? When it comes to innovations, data Integrity, technology advancement, where is Indian pharma sector standing? How are young pharma companies growing despite myriad challenges? Which category looks attractive to investors? What are the recent interesting trends and under-leveraged categories that is worth betting on? Is consolidation the way forward?

2:00pm - 2:50pmPanel IV: Evolution of the tertiary care business models - Impact of strong regional plays
Besides a few large tertiary care chains of hospitals, a larger play in tertiary care is seen from strong regional players dominating sizable market shares in their own regions. With a strong know how of key market drivers, demand-supply analysis and customer demographics, these regional players have been able to get the model right for tertiary care and have been successful in providing affordable & quality healthcare services. Emergence of regional brands in tertiary care has been welcomed well by the investors as we’ve seen significant investments supporting their businesses. What’s the key behind evolution of regional tertiary healthcare service providers? Is the trend drifting from national to regional plays? How is the regional tertiary care opportunity evolving and which all specialties’/specialized healthcare services are most promising?

2:50pm - 3:40pmPanel V: Understanding the context of “Make in India” for Med-tech: Indigenous medical devices, medical consumables & equipment
Medical Technology in India has seen signification traction with Indian medical devices, consumables and equipment finding market in the international borders besides the home ground. Adding to this, the “Make in India” campaign will further strengthen India’s position in medical technology as it brings newer players to make in India besides strengthening the current players. Backed by demand and larger pool of talent available, we understand what are the key trends driving med -tech developments? To address the growing needs of growing Indian consumers, what kind of innovations and customization are entrepreneurs bringing to the table? Is the med tech opportunity yet to grab larger interest from investors? Considering the price sensitivity, how are Indian entrepreneurs tackling pricing & quality issues? Are there any lucrative policy incentives to “Make in India” for med tech? What steps can be taken to make the sector less import driven? Will setting up of med-tech industrial parks have a significant impact on local device manufacturing industry?

3:40pm - 4:30pmPanel VI: Innovations in Diagnostics - Genomics and emerging preventive diagnosis
Moving ahead of the large diagnostic chains, specialized chains offering high end diagnostic services there seems to be an emerging segment around genomics, genome testing and preventive diagnostics. Services as such as disease susceptibility, in born talent & traits are now emerging as newest set of diagnostics services offered in the market. How critical can be such services in the coming future? Do we see a sizable market for such services in India? What can be the contribution of genomics advancements in upgrading drug discovery processes, early diagnosis and precise treatment of patients? How helpful can the genomic research be to pharmaceutical & biotech companies? What role can be played by sequencing technologies, genomics advancements in decoding critical patient needs and improving the overall effectiveness of healthcare?

5:30pm -6:30pmVCCircle Healthcare Awards 2015
On the evening of September 15 we will be hosting the 3rd edition of VCCircle Healthcare Awards aiming at recognizing and rewarding outstanding healthcare providers who have not just made real differences in the patient’s life but have also created a culture of innovations & excellence across the Indian healthcare industry.

VCCircle Healthcare Awards 2015 will recognise companies across following categories:

• Best Multi-specialty Tertiary Care Hospital Chain
• Emerging Tertiary Care Hospital of the year
• Indian Med-tech Company of the Year
• Diagnostic Services Company of the Year
• Single Speciality Services Company of the Year
• Best Healthcare Delivery Services Company of the year
• Innovative Healthcare Startup of the year
• Most Promising Healthcare Startup

VCCircle Unwind
This session will provide more networking time to entrepreneurs and investors over cocktails.

Day II, 16th September

8:30am - 9:20amTea & Networking

9:20am - 9:30amOverview of day I & welcome note

9:30am - 10:30amPanel I: Emerging Healthcare Delivery Models: Spotlight on Home Healthcare & Birthing Centres
Home healthcare is a vibrant multi-billion dollar business in the developed countries and India has just started to witness its potential as we see few emerging businesses aiming to deliver quality healthcare through newer emerging models such as home healthcare. The segment has started getting traction and has now drawn interest of entrepreneurs, investors & even large hospital chains. Similarly, specialized birthing centres are getting increasingly hotter with affluent middle class bypassing traditional nursing homes to avail ideal combination of top clinical facilities and memorable hospitality experience. While these two models are under spotlight, we understand what are the emerging healthcare delivery models gaining traction and now becoming mainstream?

10:30am - 11:30amPanel II: Leveraging Information Technology in healthcare: Hospital Management software, Patient & disease data analysis and more
Use of Information Technology is Indian healthcare industry is way below as compared to some of the other developing nations. There are very less or no information management systems which can help capture critical information on illness, diseases, treatments & patients residing with fragmented healthcare service providers across the country. Very few providers have now taken information management on priority however that is also limited to capturing patient registration data. Be it hospitals, diagnostic services, pharma companies to medical technology players, there is no intersection of information technology when it comes to clinical data. While this poses a great challenge to the industry, entrepreneurs have latched on to this as a huge opportunity and are creating systems which can help large healthcare players deliver services more efficiently. What are the opportunities in creating new-age disruptive hospital management systems, clinical information systems & other emerging segments? How do investors see this as an opportunity? Relevance of Information management systems capturing clinical and patient information etc in diagnostics and research? How does this information availability impact the overall healthcare innovation scenario in the country?

11:45am - 12:15pmShowcase Session - Healthcare Startups
A curated platform featuring five innovative companies in the healthcare space who will come on the stage and make presentations on their path-breaking ideas, business models and niche opportunities.

12:15pm - 01:05pmPanel III: Digital Health Play in India - Healthcare Content Management, Patient & Doctor Management Apps, Online Pharmacy, self-diagnostic devices & fitness bands
To enable healthcare services reach the audience in most appropriate manner, digital health services are playing a key role. Digital health play in India is seeing entrepreneurs disrupting doctor-patient management systems, information sharing gaps, online pharmacies, docpreneurs disrupting the healthcare delivery models through technology, technopreneurs bringing in self-help diagnostic devices and fitness products. All these and much more innovations on the intersection of digital, technology & healthcare services are helping the industry and users at large. What role can digital health play in helping main stream healthcare providers in long run? How can ecommerce intervention help in delivering healthcare products & services more efficiently?

Ms. Shah has evolved Metropolis from its single pathology laboratory status to a fully integrated multinational chain of 125 diagnostic centers and 800 collection centers across the globe including UAE, South Africa, Mauritius and Ghana.

Ms. Shah is an eminent industry spokesperson and has been featured as a speaker at various National and International forums such as TedEX, Harvard Business School, CII (Confederation of Indian Industry), IIM (Indian Institute of Management) - Ahmedabad and many such reputed institutions. She has also been elected the Secretary of the IAPL (Indian Association of Pathology Laboratories) and is the Chairperson of the ‘FICCI Health services Western Subgroup’ that drives policy decisions at the Center.

Amit Soni joined GA in 2008 and has worked in our New York, London and India offices. He is based in the firm’s Mumbai office where he focuses on investments in the firm's Internet & Technology sector, including IT services.

Amit is closely involved with General Atlantic’s investments in BillDesk, CitiusTech, IBS Software and Mu Sigma. He has played an active role in General Atlantic’s investments in House of Anita Dongre (formerly known as AND Designs), Kaspersky, MedExpress, Red Ventures, Hexaware and Infotech Enterprises.

Prior to General Atlantic, Amit worked at 3i Plc’s India office and focused on investments in the automotive, media, and oil & gas sectors. Amit has previously worked with the Bill & Melinda Gates Foundation and was instrumental in setting up the largest HIV/AIDS prevention program in India. He has also been a consultant with McKinsey & Company.

Amit earned his M.B.A from The Wharton School, University of Pennsylvania and his Bachelors of Technology in Electrical Engineering from Indian Institute of Technology, Delhi.

An engineer to the core, Ambar is the founder and Managing Director at Wrig Nanosystems Pvt. Starting the company in a humble manner, Ambar has been successful in developing new technology products and products. He is responsible for various responsibilities at Wrig, including product development, strategic & financial planning and managing day to day operations.

Before founding Wrig, Ambar had had diverse experience across various industries. He worked extensively in bioelectronics in different assignments and project in different research labs in India and overseas. During his technical assignments he has dealt with challenges ranging from controlling the placement of DNA nanowires to evaluating extent of corrosion induced by seawater microbes. Apart from technical experience, Ambar has worked with private equity firms and management consultancies. In his corporate assignments he has been involved in financial planning, valuation of various companies, development of business processes and designing business strategies.

Ms. Anu Acharya is the CEO of Mapmygenome India, a genomics company whose vision is “Better health using technology”. She is a Co-Founder of Ocimum Biosolutions, which she led as the CEO (2000-March 2013). She is an alumnus of IIT Kharagpur and University of Illinois where she has two Post Graduate degrees in Physics and MIS.

Awards and honors include member of Young Leaders Forum (British High Commission, 2013), Young Global Leader (World Economic Forum (WEF) 2011), Entrepreneur of the Year (Biospectrum, 2008), Astia Life Science Innovators Award (2008), and 25 Tech Titans under 35 (Red Herring, 2006).

Arunima Patel is the founder of iGenetic Diagnostics. She has over a decade of experience in healthcare investing, strategy and marketing. Her prior work experience includes 7 years stint at Actis Private Equity focusing on healthcare investing where she has evaluated and managed investments across healthcare delivery business across Asia. Prior to Actis, Arunima has worked at Prudential at UK and IBM.

During her stint at Actis PE she managed a US$50m investment in Sterling Hospitals, the largest tertiary care hospital chain in Gujarat. As the lead investment manager, Arunima was a key part of the team in driving growth and margin improvement at the chain.

Apart from iGenetic, Arunima has also founded the leading dental chain in Delhi called My Family Dentist.

She holds a post graduate diploma in management from Indian Institute of Management, Ahmedabad (IIMA) and a degree in Electronics & Communications engineering from National Institute of Technology, Bhopal (NIT, Bhopal).

Arvind, Founding Member of Attune Technologies, has around 10 years of experience in areas of Entrepreneurship, Enterprise Technology Architecture Management, Pre-Sales and Client Management across different International Geographies. Having done BE and MS in Software Systems, Arvind was closely associated with providing IT Solutions to the global healthcare market. As a Technology Specialist at Philips Medical Systems, he was responsible for the design and development of the state of the art Picture Archiving and Communication System (PACS) product. During his stint in iSoft, Arvind managed software architecture for the world’s largest civilian IT project - Connecting For Health (CFH), National Health Service, UK.

While evolving IT Solutions for global healthcare market, Arvind was perplexed with the low levels of IT penetration in domestic healthcare market. He immediately saw a huge gap in the market and market in the gap. Having made up his mind to launch his own venture, Arvind enrolled himself for an MBA program in IIM Calcutta to equip himself with tools required to establish and run a business entity. He simultaneously started identifying individuals for his start-up team and launched Attune Technologies in the year 2008. Arvind is currently providing the leadership and handling operational & strategic initiatives at Attune.

Besides Attune, Arvind is the Founding and Management Committee member of Gnyan Prabodh, an NGO working towards eliminating illiteracy in India. He was one of the founding members of the trust with a modest sponsorship of 3 students in year 1999 and grew the trust to sponsor 313 students in the year 2007. In total, 700 students with the sponsorship amount of Rs. 17 Lakhs has been disbursed by the trust. Arvind is also a Professional cricketer and has represented his district and state in various tournaments.

Dr. Ajay Nair is the Co-Founder & Managing Director of MeraDoctor. With over 200,000 patients and growing, MeraDoctor is one of the fastest growing digital health services in India! In the next 2 years, they aim to become the largest primary care service in the country by patient numbers. Before MeraDoctor worked with Acumen Fund in New York and Nairobi with a focus on Health, Energy and Capital Markets. He is a trained physician who graduated with an MBBS from Grant Medical College, Mumbai and an MPH from Harvard University.

Ashish leads the Healthcare practice for Deal Advisory in KPMG India. He has advised on several transactions in the healthcare space in the last 8 years for both PE and strategic investments and is associated with transactions in both national and regional healthcare players. He is a Chartered accountant by profession and graduated from SRCC in Delhi University

Ashwin Naik is the Founder & Director of Vaatsalya Healthcare, an award winning social enterprise, focused on building a network of hospitals in Tier II and Tier III towns in India. While 70% of India’s population lives in semi-urban and rural areas, majority of the healthcare facilities are in Urban areas and not accessible to these families. Vaatsalya is bridging this gap by building primary and secondary care hospitals in semi-urban and rural areas. Vaatsalya currently has eight hospitals in Karnataka and one in Andhra Pradesh, totaling 600 + beds and is the largest hospital network of its kind in India.

Winner of the Inaugural Porter Prize in India for value based healthcare, Vaatsalya has been recognized as the Most Innovative Healthcare Company by VCCircle in 2014 and by Fast Company in 2013, Winner of the BiD Challenge India 2007 for the best business in development in India, LRAMP Award for Innovation 2008, Sankalp Award for Social Enterprise 2009 and Frost & Sullivan Healthcare Excellence Award 2010 for its innovative business model.

He is also a Resident Fellow at Ashoka, a pioneering network of social entrepreneurs worldwide and Chairs the National Association of Social Enterprises, India.

Ashwin is a trained physician and has written and spoken about leadership, entrepreneurship, rural health and social entrepreneurship at various forums around the world, including World Health Congress, NHS Alliance, Ashoka Future Forum, Global Philanthropy Forum, and Africa Health summit (KPMG).

Ashwin has been recognized as a Economic Times Leaders under 40, Young Global Leader (YGL) 2012 By World Economic Forum, Young Leader by Asia Society Asia21 in 2011, Senior Ashoka Fellow in 2010, Finalist for the India Social Entrepreneur of the Year Award 2010 by Schwab Foundation, Ted India fellow for 2009. Dare Magazine India in its April 2011 edition profiled Ashwin as 50 inspiring Entrepreneurs of India.

Ashwin has a medical degree from Karnatak Medical College, Hubli and a Masters from University of Houston, Texas.

Previously, he was the Vice President of Business Development and Informatics at Triesta Sciences, a clinical genomics company. Ashwin has been part of the human and mouse genome projects at Celera Genomics. He was instrumental in coordinating multidisciplinary teams to compile and analyze human and mouse genomes, leading to two publications in the journal Science. He holds three patents and has contributed a book chapter on Origin of Life.

A visionary and an able business administrator, Dr. Velumani proves amply clearly to industry that , “Focus gives Success”. Born in a small village near Coimbatore, South India, to a landless farmer, today he owns and operates this Industry leader, Thyrocare, a brand worth over Rs. 2000 crores. Began as a mathematician, became a Pathologist, after his PhD in Microbiology from BARC/ Mumbai University in Thyroid Biochemisty. As a Research scientist and Teacher he worked for 14 years in BARC and then in Business he has become an administrator.

An infecting motivator, has succeeded in converting educated as employable, graduates as professionals, individuals as entrepreneurs, vendors as partners, family members as wealthcreators and of course by his unique way of transforming intimidating problems into opportunities for prosperity.

Dr. Ajai is the founder and Chairman of HCG. He completed his M.B.B.S from St. John's Medical College, Bangalore and Residency in Oncology from University of Virginia, Charlottesville. He did his Fellowship in Radiation Oncology & Medical Oncology from the world renowned M. D. Anderson Cancer Center, Houston.

With over 35 years of experience in the field of oncology at some of the reputed cancer centers in US. Dr. Ajaikumar had a vision to start a world class cancer care center with the latest technology and best of expertise in India. He joined a group of specialists at Bangalore in 1989 and started the 'Bangalore Institute of Oncology' the only private cancer hospital at that point in time in Bangalore.

Chandra Sekhar has an extensive work experience of over 24 years and has played a significant role in the Health Care and Health Insurance Industry in India for over 15 years. He currently holds the position of President - Corporate and International of the Apollo Hospitals Group and is responsible for spearheading the Group’s new business initiatives, new and international markets and provide strategic support to the various businesses of the Group. Besides, he also holds the position of Executive Director and a member of the board of HealthNet Global, the technology initiative incubated for Telehealth and Remote monitoring Devices by the group and its promoters.

For 5 years, before his current position with the Apollo Hospitals Group, he held the positions of Executive Director-Marketing & Strategy of the Global Hospitals Group and Consultant- Healthcare Investments with ICICI Venture.

Prior to this, in his first stint, he had a successful tenure of nearly 10 years with the Apollo Hospitals Group. He last held the position of the Group President-Marketing with the group. During that period of nearly 10 years with the group he led the formation and business launch of a Standalone Health Insurance company in JV with the Munich Re group, besides heading the business development, marketing and brand portfolios for the hospital division, playing a key role in the growth and development of a Third Party Administration (TPA) Company. He has a deep understanding of various other spaces in healthcare such as hospital projects, Primary care Clinics, Pharmacy chain, Wellness, Disease Management, health care information technology and the healthcare BPO space. He is also the Founding Member of the CII Working Group on Health Insurance.

He has travelled widely for business development, JV projects and strategic partnerships across India, SAARC, Far East, MEA, Europe and USA.

He also has a strong academic background with an MBA from Hyderabad, India and Advanced Management Programs from the Indian School of Business and the Kellogg’s School of Management, Chicago, USA.

Chhitiz Kumar has experience cutting across several industries and financial services. Over the last 2 decades, he has worked with Johnson & Johnson, GE Capital and Philips.

Currently as head of Philips Capital India, he is responsible for debt financing and equity investments for all the 3 businesses (Consumer Lifestyle, Lighting and Healthcare) of Philips in Indian Subcontinent. He also leads the Govt. Affairs and PPP function for Philips in Indian subcontinent.

In his previous role at GE Capital, Chhitiz played several roles of increasing responsibility and structured financing solutions across an array of sectors for Indian corporates & MNCs.

With his vast experience across industries and across functions, he brings in a holistic and balanced view to a business.

Chhitiz is an alumnus of IIM, Kolkata and B.Tech (Mining) from Indian School of Mines, Dhanbad. He is a certified “Independent Director” and also a certified Six Sigma Green Belt. He is also on Advisory Board of SRM University, Chennai.

Venkat is a co-founder of Veda and has more than 16 years of hands-on experience in the investment banking business. Venkat has been a pioneer in the investment banking space in India and has been closely associated with the growth of the Indian VC/PE industry since the mid nineties. He has an enviable track record of transaction closures in private equity as well as M&A, having crafted several defining transaction across domains such as services, infrastructure and ITeS, amongst others.

Venkat is a successful entrepreneur in his own right having co-founded Mantra Consultants in 1998 (along with Vinod Kumar), a boutique investment bank based in South India, which was subsequently acquired by Ernst & Young in 2001. He was an Associate Director at Ernst & Young before co-founding Veda in late 2003.

Venkat is an Associate Member of the Institute of Company Secretaries of India. He is a regular speaker in industry forums and his views on are often quoted in the business media. He enjoys strong and long standing relationships with several leading private equity funds and their managers.

Dr. Dharminder Nagar is the Managing Director of Paras Healthcare. He has the unique advantage of being a doctor, hospital administrator and entrepreneur all in one. Several qualifications that include an MBBS from Mysore Medical College, MPhil from BITS Pilani, MS from Imperial College and MBA from Harvard, have propelled this young and dynamic MD to the forefront of healthcare. Dr. Nagar’s missionary zeal to make health services accessible to all Indians led to the establishment of Paras Healthcare, which is founded on the three principles of affordability, accessibility and quality.

Dr. Nagar’s keenness to deliver accessible tertiary medical care to people of every social strata is obvious from the cutting edge technologies and infrastructure present in all hospitals, at affordable prices. He supports every Indian’s right to healthcare and plans to introduce new models of healthcare delivery that empower patients at every stage, from the primary to the tertiary. Imparting awareness about healthy living practices is an important component of services at hospitals. A strong rural marketing strategy that includes Telemedicine supports the activities of Paras HMRI in Patna also enables communities in the far flung areas of Bihar, Jharkhand and Haryana to access medical care.

Dr. Nagar is a leader with a strong social bent of mind, committed to realizing his vision of providing healthcare solutions for the common man. Corporate social responsibility is integral to Paras Healthcare, and the three hospitals run by the group- Paras Hospitals in Gurgaon, Paras Bliss in South Delhi, Paras Bliss in Panchkula ,Paras HMRI in Patna and Paras Global Hospital in Darbhanga- were built in response to unmet healthcare needs of the rural and urban people in the region. Hailing from a rural background, Dr. Nagar is determined to bridge the gap between the rich and poor, and has built hospitals in areas that lack health infrastructure, specialists and tertiary care. Ultimately Dr. Nagar perceives Paras Healthcare as a partner in health for the common man.

Dr Dharminder Nagar has been awarded the Entrepreneur of the Year (2015) Award at the India Health & Wellness Summit 2015 and Dynamic Healthcare Entrepreneur of the Year 2015 by Six Sigma Healthcare Awards at the World Entrepreneur Summit.

A well known management expert in Healthcare, Dr Batra is the Founder Promoter and Director of Cygnus Medicare. Before starting this venture, Dr Batra was working as CEO of Primus Super specialty hospital, Chanakyapuri. He was one of the key players in the success story of the Primus Group. He was instrumental in establishing a 100 bedded hospital at Abuja, Nigeria under the banner of Primus Hospital. With over 30 years of experience in the Healthcare Industry in India and other countries, he is one of the well known names. He is aggressively involved in administration, planning and development of the nine hospitals now under Cygnus Group. He has actively participated in healthcare projects for tribal areas, for patients needing free dialysis, and free education to under-privileged. He is attached to many leading healthcare institutes in Delhi NCR as Medical Advisor.

Gareth Jones was educated at Manchester Grammar School and then at Edinburgh University where he studied Medicine. At Edinburgh he excelled in both sport and flying – as a member of the University Air Squadron. Graduating in 1977, Gareth completed his pre-registration ‘house jobs’ to register as a doctor before opting to join the Royal Air Force, not as a doctor, but as a pilot.

Following 3 years of successful training, Gareth joined his first operational Squadron in 1981 - No. IV (AC) Sqn flying Harriers in Germany. An illustrious career in the RAF followed, principally flying Harriers or undertaking staff posts in support of the Harrier Force. He was awarded a Queen’s Commendation for Valuable Service in the Air in 1990, then an OBE in 1998, and retired from the RAF as a Wing Commander.

In his final RAF years, Gareth completed a self-sponsored Warwick University MBA and graduated in 1998. Wishing to join a small entrepreneurial enterprise, Gareth joined Charles Walsh and a very small Healthcare at Home (HAH) in January 1998 as Business Development Manager. Since then, he has helped Healthcare at Home achieve significant growth and great success. He was appointed commercial director in 1999, led the company’s strategic development team for a time, and then headed up the PharmaServices Division; finally, he was International Director, developing business in Germany, Switzerland, Ireland and Australia. Gareth qualified as a Chartered Director with the Institute of Directors in 2006.

Gareth left HAH UK in early 2012 in order to set up, with Charles Walsh and the Burman family (owners of the Dabur Group), a new joint venture in India “Health Care at Home India Pvt Ltd”. He is currently Chairman of the company and spends much of his time in India helping to develop the business.

He is married to a full-time General Practitioner, has 2 adult sons, and lives in Rutland UK.

Gopi Natarajan is the visionary entrepreneur who forecast the enormous opportunity in the healthcare BPO/KPO industry when it was in the nascent stage. From a technical professional, Gopi transformed himself gradually into an entrepreneur and established Omega Healthcare in 2004, which today has grown into a large enterprise having an employee strength of over 8,500 and growing at the rate of 30-35% year-on-year. The organisation is a leader in the space and constantly engages in training and upgrading the skills for its employees.

Gopi is the Co-founder and CEO at Omega Healthcare and has more than 25 years of experience in the Healthcare Industry both in the US and India. Prior to Omega, he led a $40 million medical billing company in the US with 1,000 employees, of which 250 were located in India. He has also gained valuable experience in IT and BPO/KPO outsourcing during senior management stints with Aetna (NYSE: AET), EDS (NYSE: EDS) and Healtheon/WebMD (NASDAQ: WBMD). Having a brilliant track record in leadership, mergers, acquisitions and integration of companies, Gopi has been instrumental in leading small sized companies and growing them into mid/large companies. He now spends a significant amount of his time in India, overseeing the operations and growth of Omega Healthcare.

A healthcare professional with exceptional leadership skills, Dr. Harish Pillai joined the Aster DM Healthcare Group as the CEO of Aster Medcity in the year 2013. Set in 40 waterfront acres, Aster Medcity Kochi is a USD 300 million green field medical township project. The Phase I of the project, which comprises one Multispeciality Hospital, eight separate Centres of Excellence, is complete. Aster Medcity is the first quaternary care hospital in Kerala to win the JCI Accreditation. The hospital is first in India to receive a host of accreditations and awards within one year of opening and includes the NABH Accreditation, Green OT (Operation Theatre) Certification by Bureau Veritas, ISO 22000 Certification and the first-ever NABH Award for Excellence in Nursing.

In just 2 years, Dr. Harish Pillai was promoted as the CEO of all Aster DM Hospitalsin Kerala, which includes the 670-bed Aster Medcity Kochi; MIMS Calicut, India’s first NABH accredited 600-bed tertiary care hospital; MIMS Kottakkal, a 150-bed secondary care hospital and DM WIMS, Wayanad, a 300-bed hospital and medical college.

Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. During his tenure as the CEO, he was the functional head of the 1300 plus staff team and helped the organisation attain consistent annual growth of over 16% even during the Egyptian Revolution in the year 2011. Under his leadership, the Hospital won the JCI accreditation and charted a growth turnover from 16.65 million USD in 2006 to 43.7 million USD in 2012 with an EBITDA of 18%.

Dr. Harish Pillai, who did his medical schooling at the Kasturba Medical College, Mangalore, started his career in hospital management with the Apollo Hospital group after completing his first Masters in Hospital Administration from the Apollo Institute of Hospital Administration, Hyderabad, where he won the Dr Prathap C Reddy Award for Overall Excellence. He then went on to complete his Masters in Business Administration - International Hospital and Healthcare Management from the Frankfurt School of Finance & Management, Germany, where he was awarded the Best Student for his distinguished academic record. He then joined the Belhoul Speciality Hospital, Dubai, UAE, as General Manager - Operations, and was soon promoted as the Hospital Director.

One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai has been nominated to the board of Members of the Joint Commission International (JCI) Standards International Advisory Panel. He is the current Convener of the Healthcare Panel of Confederation of Indian Industries - CII Kerala State Council; the past Chairman of Board of Directors of New Cairo British International School, Egypt and the past President of the Indian Community Association of Egypt.

Dr. Harish Pillai, who was featured among the top 25 healthcare influencers in India by the Healthcare Executive Magazine (January 2015 edition), won the Best CEO of the Year Award (2015) at the CMO National Awards for Healthcare Excellence.

Himanshu Laiker Director - Strategy, Business Development and Strategic Accounts, Medtronic South Asia

Himanshu Laiker, is the Director for Strategy, Business Development & Healthcare Solution at Medtronic India Subcontinent with BS & MBA from University of Minnesota-Carslon School of Management.

He joined Medtronic, PLC. as a Financial Analyst in June, 1999 at corporate headquarters and since then has worked in IT, marketing, business development, strategic planning, healthcare solution across three continents (US, Europe & Asia) as well across businesses like cardiac, diabetes, & spinal.

In his current role, he is responsible for leading and managing the Strategic plan, driving new Business Development/Alliances as well new business for Healthcare Solutions Service model.

Jagdish Moorjani has spent over two decades across various leadership roles in technology and business process outsourcing. As the Chief Operating Officer of CitiusTech, Mr. Moorjani is responsible for project quality and delivery for all CitiusTech clients worldwide. He plays a key role in Quality Assurance and competency development initiatives directed towards client engagement, satisfaction and confidentiality.

Before CitiusTech, Mr. Moorjani co-founded TransWorks, where he was responsible for global operations, finance, infrastructure, commercial and legal. He led many key initiatives at TransWorks, including its first COPC certification, making TransWorks the first company in the world to be certified with COPC 3.2.

Mr. Moorjani holds a Bachelor’s degree in Engineering from the Indian Institute of Technology (IIT). He also has a degree in Law from the University of Bombay, specializing in commercial and tax law.

Mr. K. Chandrasekhar (KC) is the CEO and an executive board member of Forus. KC received his Master's of Science and Technology from Birla Institute of Technology & Science (BITS Pilani), PGDMM from Annamalai University and Global Manager Program from Indian Institute of Management, Kolkata. KC has a successful track record of over 26 years in handling Business Development, Business Strategy, Operations Management, Partnership Management & Sales Management portfolios for major Semiconductor and Software Companies. KC has extensive experience in handling customers & partners in USA, Europe, Asia-Pacific & Middle East Markets. He has worked in Senior management positions with NXP Semiconductors, Philips, Alliance Semiconductors, etc. KC is a Certified Corporate Director from the Institute of Directors. KC loves classical music, reading and cricket.

Manish Gupta co-founded Indegene in 1998. He is Chief Executive Office and is responsible for overall realization of the company’s vision. In the last decade, he has led the company’s strategy, M&A, capability development and globalization initiatives. He spends his time across the company’s US, China and India offices driving thought leadership, organizational development and market expansion initiatives. He is one of the industry’s foremost leaders in building deep multi-national healthcare focused teams. Prior to starting Indegene, he was associated with Infosys Technologies. He holds a B. Tech from IIT–BHU, Varanasi, and an MBA from the IIM, Ahmedabad.

Meena is one of India’s foremost business leaders and most successful entrepreneurs with nearly three decades of experience in industries including healthcare, consulting, technology, outsourcing, education and e-commerce.As the MD & CEO, Meena heads Portea Medical, India’s largest and fastest growing home healthcare company, which she co-founded in July 2013.

Till February 2013, Meena was a promoter and board member of TutorVista, and CEO and MD of Pearson Education Services.As a partner of the platform, Growthstory.in, she is also co-promoter of nearly a dozen, new-age Internet / Technology enabled start-ups. A few of them that are leaders in their category include Bigbasket.com - India’s premier e-grocery retailer, home solutions company - HomeLane, Food Tech company - FreshMenu, and Bluestone.com – India’s leading online jeweler.

Meena has also co-founded Customer Asset, one of India’s pioneering BPO companies which she sold to ICICI OneSource. She also had a five year stint with Microsoft India‚ during which she set up multiple business units including Microsoft Consulting‚ Internet and Application Development/Business services units. During the initial 11 years of her career, Meena was with PricewaterhouseCoopers and with NIIT.

Meena is a PGDM holder from IIM Calcutta has a graduate degree in Physics from the Madras University.In 2015, Meena was among the 7-member jury for the inaugural Economic Times Startup Awards and in November of the same year, was selected by Fortune India as one of the 50 'Most Powerful Women in Business.'

Meena serves as a member of the CII-Innovation & Entrepreneurship Council.

Mihir is a US based mHealth entrepreneur of Indian origin. A computer engineer by training and a socially-motivated entrepreneur by profession, Mihir is passionate to address health disparities for the many, in the developing world. In 2009, he founded UE Lifesciences in Philadelphia, Pennsylvania to lead the effort in developing innovative breast health examination tools for regions where vast majority of cases are diagnosed at late stages. Mihir is also the Founder of HEALTHEE, a convenience driven primary healthcare service for urban Indians.

Monika is a founding partner at Arete Advisors and leader of the healthcare practice. She has c.16 years of consulting experience including over 13 years in healthcare advisory. During this time Monika has worked with more than 100 leading firms, private equity funds and government departments. She has supported them in improving access to healthcare services, formulating strategies for growth, improving operational performance, making investment decisions and building their people’s capabilities. She has provided advisory services across over 50 markets in the country and other South East Asian and Middle Eastern countries. She has an in-depth understanding across sub-segments in healthcare delivery including multi-specialty hospitals, specialty centres and day care, retail formats of healthcare delivery and laboratory and radiology diagnostics.

At Areté she has advised leading healthcare groups in the country and led commercial diligence/post-investment performance improvement exercises for leading global and Indian Private Equity players with interest in healthcare.

Prior to founding Areté, Monika was the President and CEO of the Corporate Advisory Division at Feedback Infra. She is a management graduate from IIM Ahmedabad and a post graduate in Physics from Delhi University.

Mudit Vijayvergiya is the co-founder of Curofy, India’s first verified social network of doctors. With Curofy, he is striving to engage doctors on a single mobile platform for professional discussions. The whole healthcare industry can communicate with doctors via mobile phone with the help of technology thus removing the inefficiencies prevailing the system today.

Born and brought up in a family of doctors, Mudit is a dual degree graduate in chemical engineering from IIT Delhi. Prior to founding Curofy, Mudit worked with Axtira Inc on health informatics and analytics for an year. He has been an active part of various entrepreneurial avenues like Jagriti Yatra, TIE, youth forums and draper university in silicon valley.. While at college, multiple internships with healthcare startups exposed him to the ground realities of the sector in India and that gave birth to Curofy. He is passionate about sports and travelling.

Curofy provides Doctors the opportunity to seek opinions from other doctors, apply to jobs with a single click, read latest medical news on the go. It also bridges effectively the yawning demand-supply gap of superspecialists in the country. With the high engagement numbers of doctors, Curofy is all set to include businesses who want to reach out to doctors without intruding the latter.

Dr. Mohammed Rehan Sayeed is the chairman of Motherhood Hospitals, a position he has held since he founded Motherhood India in January 2011. As the chairman of Motherhood India, he overlooks and directs all the activities across all Motherhood units, based in Bangalore, Chennai, and Hyderabad.

Dr. Rehan received his DNB in General Surgery & Cardiothoracic from National Board of Examinations, New Delhi. He is an MD, with Fellowship in Pediatric cardiac Surgery from The Children’s Hospital of Boston Harvard Medical School, Boston, MA. He also holds MD, Fellowship in Heart failure Surgery & Cardiac Transplant from The Cleveland Clinic Foundation, Cleveland, Ohio. In addition, he has a Fellowship in Adult cardiac Surgery from Boston University Medical Center, Boston, USA.

A renowned cardiovascular and thoracic surgeon, Dr. Rehan, has practiced extensively in India and abroad. He has performed over 10,000 cardiac and 4,000 thoracic surgeries. He has done over 2,000 mini bypass surgeries with 99.5% success rate, for which he was nominated to the “Robert Emory Young Innovator Award” by the International Society for Minimally Invasive Cardiac Surgery (ISMICS). He has successfully completed more than 3,000 for the entire range of minimal access cardiac surgeries, and over a 500 endoscopic heart surgeries. A pioneer in the field of hybrid cardiac surgery in India, He has extensive experience in both adult and paediatric cardiac surgery.

In addition to having performed an array of surgeries, Dr. Rehan has many firsts to his credit. He is the first doctor to do an endoscopic closure of a complex congenital heart defect (partial anomalous venous return) in the world. The first endoscopic closure of atrial septal defect (ASD) and the first hybrid coronary bypass surgery (CABG) in south India was done by Dr. Rehan. Dr. Rehan holds the credit of being the largest single surgeon series of mini bypass surgery in the world and the largest single surge on series of minimal access cardiac surgery in India.

Dr. Rehan has vast research experience in various facets of cardiovascular and thoracic surgery and has presented many papers at several national and international conferences. Besides, he has also aut hored chapters on valve surgery in major cardiac surgery textbooks. Dr. Rehan is a member of the American College of Chest Physicians, Royal College of Surgeons of Edinburgh, and the Cleveland Clinic Alumni. He is also a much sought after speaker at many national and international scientific gatherings.

Nitish Agrawal is a Managing Director at Veradis, a healthcare focused investment banking advisory firm. Based in Bengaluru, Nitish has advised on domestic and cross border M&A as well as equity fund raising transactions across all segments of healthcare including large hospital chains, single speciality formats (maternity, IVF, etc), diagnostics and medical devices, with a cumulative experience of evaluating over 20+ deals in healthcare.

Nitish has had over 15 years of leadership experience in the past across Allegro Capital, GE Capital & Genpact. He is an engineer from IIT, BHU and holds a Post Graduate Diploma in Management from IIM Calcutta

Piyush has over 6 years of experience in the financial services industry. Prior to his work with Tano, Piyush was working with IL&FS Ltd. in investment banking for over 3 years and was part of the team headed by Hetal Gandhi. Before that Piyush worked with Export Import Bank of India in Corporate Banking and with First Global Securities as an equity analyst.

Piyush is a Postgraduate in Business Administration from Management Development Institute, India and a Graduate in Commerce from St. Xaviers College, India. He is also a CFA Charterholder.

Praneet Singh is a Managing Director at Siguler Guff and a member of the Investment Committees for the BRIC Opportunities Funds. He is a senior member of the Firm's investment staff and is actively involved in managing investments in India and the frontier markets. Mr. Singh joined Siguler Guff in September 2008 and brings a unique mix of operations, marketing and consulting experience, as well as expertise in the healthcare and consumer sectors, to the BRIC investment team.

Prior to joining Siguler Guff, Mr. Singh headed the $325 million Indian operations of Piramal Healthcare Limited, India’s fourth largest pharmaceutical company. Prior to that, he worked for more than seven years in the Mumbai, Delhi, Boston and Santiago offices of McKinsey and Company, focusing on operations, marketing and strategy. Mr. Singh also worked in marketing at Procter & Gamble in India and Southeast Asia for five years. He was born and raised in Delhi, India.

Mr. Singh holds a B. Tech. in Mechanical Engineering from the Indian Institute of Technology Delhi and an M.B.A. from the Indian Institute of Management Calcutta.

Prashant is the Founder & CEO of 1MG, India's #1 m-Health application. With over 3 M downloads, and ~5 M monthly visits on the platform, 1MG is the favorite app for health consumers across the country.

Prashant was born and raised in New Delhi. He is an MBA from Stanford Graduate School of Business and graduate from Indian Institute of Technology - Delhi (IIT-D). Prior to 1mg, Prashant was the co-founder & managing director of HealthKart, which he started in 2011 and took it to the position of India's #1 Nutrition eCommerce company. Till 2009, before he returned to India, Prashant worked at McKinsey & Company in San Francisco where he focused primarily on Healthcare. He started his career with the Business Leadership program at Hindustan Unilever India, where he worked in pan Asia roles for Innovation development and operations.

Prashant returned to India in 2010 to pursue entrepreneurial opportunities in the burgeoning healthcare technology space, where he then co-founded HealthKart, before setting up 1mg earlier this year.

A senior Professional - medical graduate having post-graduate qualification in Hospital Administration; and Health & Family Welfare Management; with more than 32 years of experience as Healthcare Business Manager including 7 years as clinician. Recipient of 1999 Yoshioka / Japan Hospital Fellowship of International Hospital Federation; and listed in “Pride of Rajasthan” as an outstanding achiever in healthcare sector. Bestowed with unique attributes of leadership qualities, people management skills, out of box thinking, sound analytical capability, entrepreneurial instincts, and flair for academics & research coupled with exceptional ground level execution skills to deliver good financial and operational performance consistently. Have solid grounding in different facets of health system encompassing - healthcare delivery, its organization & management, development & financing, quality & accreditation and advocacy. A frequent speaker at conferences and public fora, have published multiple articles focusing on Planning & Design of Health Facilities, Operations & Management, IT in Healthcare including Tele-Medicine, Quality & Accreditation, Health Insurance; and Globalization & its Impact on Health Sector. Regularly conducts Management Development Programmes including Leadership and Team Building Workshops.

Prem Pavoor is a Managing Director at FIL Capital Advisors (India) Private Limited and leads investments in the life sciences, healthcare, manufacturing and agricultural inputs sectors.

Prem was previously based in the United States with McKinsey & Company’s Pharmaceutical and Medical Products Practice in New Jersey where he advised clients on areas that included R&D, business development, manufacturing optimisation and post-merger integrations.

His patented doctoral thesis work, performed at the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital, focused on enhancing the performance of medical implants. He was awarded the MIT-OMNOVA award for Excellence in Polymer Research.

Prem holds a Bachelor’s degree in Chemical Engineering from the Institute of Chemical Technology (formerly UDCT), Mumbai, a MS and Ph.D. in Chemical Engineering Practice from MIT and an MBA from MIT Sloan.

Rajiv Vasudevan, founder of AyurVAID, is responsible for providing leadership and operational excellence to all aspects of the business.

Rajiv has worked in a diverse set of leadership roles in the private and government sectors including operations as well as profit center management roles at Godrej and Motorola (Country Head, PSG, India & SAARC). He also served the Government of Kerala as CEO-Technopark, Director-Kerala State IT Mission, and later as Special Officer - Biotechnology.

Rajiv holds a B.Tech (Hons) in Mechanical Engineering from NIT-Calicut and a MBA from the prestigious Indian Institute of Management, Calcutta. He qualified as an ‘assessor’ of the National Board for Accreditation for Hospitals & Healthcare Providers (NABH), Quality Council of India in 2007, making him the first person from the Ayurveda sector to receive this accreditation. Further, Rajiv is a member of the technical committee constituted by the Government of India for formulation of NABH accreditation standards for Ayurveda hospitals.

He has served on the Board of Directors of State Bank of India, Kerala LHO, and is currently a member of the Board of Governors of his alma mater, NIT-Calicut.

With over two decades of experience in leadership positions in the finance domain, Ramesh is the CFO, Lupin Limited. His areas of responsibilities include Business Finance, International Accounting & Taxation, Risk Management and is also responsible for managing cash flows, cost management, Treasury, Investor Management and the Corporate Planning department for the company. A key member of Lupin’s core strategy think-tank, he has guided the company through numerous Mergers & Acquisitions and enabled the company’s successful entry into some of the largest pharmaceutical markets globally.

Prior to joining Lupin, Ramesh was with Henkel, Germany where he held corporate responsibilities as the Regional Financial Controller for several countries across the Central and Eastern Europe and the Middle East. He has also worked with companies such as VST Industries, the SPIC group and the Standard Chartered Bank and has a successful track record of building finance as a key business enabler and fostering collaboration in a culturally diverse, global and matrixed workplace.

Ramesh was named as the Best Performing CFO in the Pharma & Healthcare Sector at the 7th edition of CNBC-TV18 CFO Awards 2012-13. Earlier he was named as Business Today India’s Best CFO, 2012 for “best leverage management - Large Indian Companies” across sectors.

A Lord Chevening scholar Ramesh is a member of the Institute of Chartered Accountants of India, the Institute of Cost and Works Accountants of India, the Institute of Company Secretaries in India and the Chartered Institute of Management Accountants, UK. He has also done his Senior Management Program from INSEAD, France

Ratan Jalan founded Medium Healthcare Consulting in 2009 driven by an urge to ‘make a difference in healthcare’. Innovation in business models and patient empowerment have been at the core of what he does. Ratan has over three decades of experience across diverse industries and functional responsibilities. He started his professional career in the information technology industry with HCL Technologies and then moved to advertising at Lintas (now Lowe).

Earlier, Ratan was the CEO of Apollo Health and Lifestyle Limited, part of the Apollo Hospitals Group for almost a decade. He created some of the most successful and innovative healthcare formats in the country such as a nationwide network of The Apollo Clinic and The Cradle, South Asia’s first boutique birthing centres. In 1996, as President, Ratan set up India’s first hospital architecture and consulting firm Asian Health Services, a JV with ServiceMaster, a Fortune 500 company. He was awarded the Marketing Impact Award by S P Jain Institute of Management and has been nominated as one of the 50 most influential professionals in retailing. He is an alumnus of IIT Kharagpur and Harvard Business School.

Dr. Ramesh Babu MD FACC is a Venture Partner with the Ventureast Tenet Fund, a premier seed-stage VC Fund consisting of investments across technology and technology-enabled sectors. With significant managerial and entrepreneurial experience, Dr. Ramesh brings a passion for early stage ventures, commitment to work, business acumen and a complementary rolodex. Healthcare, Education, Services (Consumer as well as Business) and Government Verticals are his key sectoral strengths.

Dr. Ramesh was Chief of Cardiology and Managing Director at Medwin Hospital. He is also the President of TiE Hyderabad and one of the Founding Members of Hyderabad Angels. He has been actively involved with Nephroplus a Healthcare startup, backed by funding from Bessemer. He has also jumpstarted various innovative initiatives like Hyderabad 10K run (the first to start these 10k runs in the country) and Health Awareness Promotion Project India (HAPPi) Hearts project to prevent Non-communicable diseases (NCDs).

Dr. Ramesh has had an excellent academic career. Dr. Ramesh Babu did his postgraduation in Internal Medicine, postdoctoral fellowship in Cardiology from PGI, Chandigarh, and Interventional Cardiology Fellowship from University of Alabama, Birmingham, USA. He was adjudged the Best Outgoing Student from the University.

Not surprising then that when you ask Dr. Ramesh what he likes, pat comes the reply, ‘Working'. But that does not mean he is all work and no play. His friends believe he is a cheerful person to have around. Dr. Ramesh lives with his wife, Dr. Srinagi, a doctor again, who is as gutsy as her better half. He has two sons and a daughter, and no, they are not doctors. He encouraged them to follow their heart and find their own calling, whether law, engineering or entrepreneurship.

Dr. R. Kishore Kumar founded Cloudnine in 2007 to realize his vision of high quality maternal and neonatal healthcare in India, on par with international standards. He saw a lot of deaths during his training in India, but hardly saw any deaths during his 16 year tenure in the developed world. There also saw what the "intact" survival of a premature baby means to the parents. Hence he had this dream of providing similar care in India, and is committed to his passion for scaling new heights in neonatology. He pioneered this concept of maternal healthcare in India with Cloudnine - a facility dedicated to providing exclusive and comprehensive services in maternal and child care. As the Founding Chairman, Managing Director and senior neonatologist, he has been instrumental in securing the pinnacle attained by Cloudnine today.

In just 7 years since inception - Cloudnine has received several awards and also has scaled up from 1 centre to currently operating 6 centres and will be 11 centres by next year - clearly they have become leaders in this segment. He has been invited by MNC like GE, Accenture for motivational speeches about leadership qualities and revolutionary role in India.

Dr. Kishore is an internationally acclaimed neonatologist who has worked in four continents over the course of his career - covering North America, UK, Asia and 12 years in Australia. He completed his MBBS from India and his DCH from Mysore University and London. He also has an MD with a gold medal from Mysore University, MRCP (Paed) & FRCPCH from UK as well as MRCPI (Paed) and FRCPI from Ireland. He has also completed his Fellowship in Neonatal ICU with an FRACP from Melbourne, Australia. Among his many achievements - he says two stick out in his mind - a happy family having a premature baby surviving intact and also getting felicitated by Bill Clinton, former US President in 2006.

Dr. Ruchi Dass is the Founder of HealthCursor Consulting Group. An award winning Physician from India with a Post Graduate in Preventive and Promotional Healthcare and with medical technology applied expertise. Dr. Dass has been involved in Healthcare IT, e-learning and ICT projects for the public/private sector in India. During this period, she has managed several projects that seek to use mobile phones and wireless technologies to accelerate the achievement of the United Nation’s health related Millennium Development Goals across the world.

Dr Dass is the Innovation Leader to UN Commission on Life-Saving Commodities for Women and Children, Washington DC, USA and is also on the Panel of HIMSS Innovation Community for Asia and Europe. Prior to becoming a “Thought leader” for m-Health, Dr Dass led the Business development and Operations of Lifetime Wellness Rx (An Apollo Group Initiative).

Dr Ruchi Dass is a judge to GSMA Global Mobile Awards 2011, 2012 and 2013. She is a part of the ICT4D team India and recently judged the most coveted “GSMA’s Best mHealth Innovation Awards 2012” in Barcelona, Spain identifying the excellence and innovation in mobile communications that can be of significance to Healthcare.

Mr Sam Santhosh is an entrepreneur with over 25 years of experience in initiating and running successful businesses.

Sam is currently the Chairman and CEO of MedGenome Inc - a genomics-based research and diagnostics company delivering the best of health care by decoding genetic information contained in an individual’s genome. MedGenome is the first mover and market leader in genomics-based diagnostics and research from India with international offices in San Francisco and Boston.

Sam is an investor and mentor for many companies and is currently a board member at Impelsys Inc, New York, ePay Healthcare, San Francisco, SciGenom Labs, Cochin, Emerge Ventures, Singapore and the Centre for Commercialization of Antibodies (CCAB) Toronto, Canada

Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 - Feb 2012. He founded Calsoft in 1992 and under Sam's vision Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft public and listed the company in the Indian Stock Exchanges. From 2004 to 2009, Sam focused on inorganic growth through eight acquisitions including companies in U.S, UK, Japan and India. Post 2009, he oversaw the sale of the Calsoft group companies to different buyers across the world.

He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India's premier institute, IIM Calcutta.

Sanjay Chaudhary joined Tata Capital Private Equity in August 2010. Prior to joining the Tata Capital Growth Fund in April, 2015, he was with the Tata Capital Healthcare Fund where he led the investments in four companies and served on the board of 2 companies. He is experienced across private equity, transactions, and strategy consulting.

As a strategy consultant, he has extensively advised private equity funds and companies on transactions. Sanjay has led and supervised more than 30 transactions and related engagements that have included strategic and business due diligences, deal structuring, fund raising, negotiations, and monitoring of 100 day agenda, post transaction closure.

Prior to joining Tata Capital, Sanjay ran his own advisory practice focused on healthcare transactions and consulting. He was one of the founder members of the India practice of Strategic Decisions Group (SDG), a boutique strategy consulting firm based out of Palo Alto. He started the transactions and private equity practice of SDG in India.

Sanjay has around 20 years of experience and has an MBA from Columbia Business School, Columbia University, New York city and Asian Institute of Management, Manila. He has a Bachelor’s degree in Engineering from Indian Institute of Technology, Roorkee.

Dr. Sanjeev K Chaudhry is an accomplished management professional, author and researcher. He is presently Managing Director of SRL Limited and Chairman of CSC Nutrigenomics Pte Limited, Singapore. He also serves on the Board of Directors of several companies and institutions in India and abroad.

SRL Limited is India’s largest and world’s leading Healthcare Diagnostics Company. The company runs a network of 250 Pathology Laboratories and Radiology Centers in India and serves over ten million people annually.

He was the South Asia head of DuPont Solae until June 2006, a position he held for eleven years. Prior to that he served as Chairman & Managing Director of Modern Food Industries and was the youngest person to head a Government of India company. He was also the first CEO of NatOleo Sdn Bhd Malaysia one of world’s largest producers of Oleochemicals.

He has a Ph.D in Business Administration from Columbia University, United States and holds a university record for Masters in Economics at Punjab University, Chandigarh.

Saurabh Arora is the Chief Executive Officer and co-founder of Lybrate, India’s first and largest mobile healthcare communication and delivery platform. With Lybrate, he is striving to make healthcare more accessible in India and bridge the demand-supply gap of healthcare experts by seamlessly connecting doctors and patients with the help of technology and letting them communicate using mobile phones.

Saurabh brings huge entrepreneurial product experience to the venture. Prior to founding Lybrate, Saurabh worked with Facebook Inc in the United States where he connected SMEs and large advertisers to their customers using Facebook Ads.

While working with Facebook, Saurabh decided to come back and fix the fundamental issue that plagued the Indian healthcare, which was inaccessibility of doctors. He noticed that people were blindly relying on chemists, who were not even qualified to prescribe medicines, for fixing their health problems. The thought of the situation being much grave in tier 2 and 3 cities, and the conviction to find out a solution, prompted Saurabh to incorporate Lybrate, where he connected patients to doctors much in the same way he connected SMEs and large advertisers to their customers using Facebook Ads in Facebook.

Lybrate provides people the opportunity to seek multiple opinions from doctors and bridges effectively the yawning demand-supply gap of healthcare experts in the country. With a strong network of 80,000 doctors from across India, Lybrate acts as the world’s largest online Out Patient Department (OPD).

Saurabh is an MBA from Columbia Business School. He pursued his Bachelor’s in Mechanical Engineering from the country’s premier Indian Institute of Technology (IIT), Delhi.

Shantanu's favorite sport is juggling. He juggles between the roles of marketing, web designing, sales, testing, HR and sometimes "that-guy-on-the-phone in the office". His focus is making sure more and more people know about me and use my services. He hails from a family of doctors and brings in insights that helps evolve my future path and strategic direction. He is passionate about travelling & music and makes sure he gets to sing in as many parties as possible. He boasts of getting a degree from IITB without any backlogs but never reveals his CPI.

Shiraz Bugwadia focuses on the Life Sciences and Infrastructure practice. Shiraz has more than 15 years of experience in investment banking and has worked extensively on deals across multiple spectrums of Life Sciences and Infrastructure sectors.

He graduated as an engineer from Mumbai University and completed M.B.A. from Melbourne Business School.

Siddharth Dhondiyal, a Director in the IVFA investment team joined IVFA in 2006 and is involved with investments in healthcare, consumer and technology sectors. Based in Bengaluru, he contributed to improving IVFA’s internal processes and developing the “The IVFA Way” - the Firm's approach to building admired businesses.

Over the last 10 years Siddharth has focused on tracking the evolution and growth of the Indian healthcare sector and has been actively involved in IVFA’s investments in the healthcare sector including Aster DM Healthcare, Manipal Hospitals, Trivitron Healthcare and Cloudnine Hospitals.

A Bachelor of Mechanical Engineering from IIT, Kanpur, Siddharth also holds a Post Graduate Diploma in Management from IIM, Kolkata and did his Masters in Business Administration from INSEAD, France. He had a six-year stint with Accenture in its strategy consulting practice, where he worked with companies in the pharmaceutical, consumer goods, industrial products and telecom industries.

Shiladitya is Co-Founder of VYOME and member of the Clinical Advisory Board. He is the co-chair of Center for Regenerative Medicine at the Brigham and Women?s Hospital in Boston and an assistant professor of medicine at Harvard Medical School. He is also the Co-Founder of Invictus Oncology, Cerulean Pharmaceuticals and Mitra Biotech.

Shiladitya's research focuses on the development of novel nanomedicines for cancer and angiogenesis-based diseases. In 2005, he was recognized as one of the top 35 innovators worldwide by MIT Technology Review magazine. He has also received the Shakuntala Amir Chand Award from the Indian Council for Medical Research.

Shiladitya is an alumnus of the All India Institute of Medical Sciences, and completed his PhD as a Nehru Scholar from Trinity College at Cambridge University and was a Fellow at MIT before joining Harvard. He has published over 35 papers, including in Nature and Proceedings of the National Academy of Sciences.

Sohil brings to NVP India more than 13 years of financial, investment banking and private equity investment experience from leading global financial institutions. Based in the NVP India Mumbai office, Sohil serves as an advisor on growth equity investments in Indian companies across a wide range of sectors, including telecom, technology, financial services, infrastructure and manufacturing. Sohil advised NVP India’s investments in Asian Genco Pte Ltd. (AGPL), NSE (National Stock Exchange of India, Ltd.), Nueclear Healthcare Limited, Sadbhav, Snowman Logistics, and Thyrocare. Sohil is also a board observer for NationWide Primary Healthcare Services.

Prior to joining NVP India, Sohil was an Executive Director in Goldman Sachs’ Asian Special Situations Group, a balance sheet investing group with over $4 billion under management. Sohil was the first executive recruited for the group’s India business in 2006 and became part of a five-member team in Mumbai tasked with building and running the India business. In this role with Goldman Sachs, Sohil was involved in making over $300 million of private equity and PIPE investments in India.

Varun Sood is CIO and Head - Strategic Initiatives at Fortis Healthcare, India’s fastest growing healthcare delivery company. He is currently spearheading efforts at integrating and transforming the company using Information technology as a key business driver and a source of competitive advantage for the company.

Prior to joining Fortis, Varun worked with Ranbaxy Laboratories Ltd and the Compunnel Software Group where, among other engagements, he worked with Price Waterhouse Coopers and telecom major, Verizon.

After garnering valuable experience in various operational roles in information technology, including business solutions and business process reengineering & optimization, Varun worked in senior positions comprehensively addressing all aspects of business. During this period he drove the integration of multiple business acquisitions from synergy evaluation to realization, conceptualized and implemented large organization development initiatives and led strategy development efforts to address critical business transformation needs.

Varun has substantial experience across multiple industries, functions, geographies and cultures, and has lived and worked in India, USA and South Africa.

Varun is the Co-Chair at the Confederation of Indian Industry (CII) CIO Forum for 2014-2015.

Vishal Bali brings with him 24 years of experience in building and leading global healthcare delivery organizations through organic and M&A driven strategic growth initiatives across Asia Pacific. His experience of managing a billion dollar integrated healthcare delivery organisation comprising Hospitals, Diagnostics, Primary Care and Daycare Speciality in diversified geographies of India, Australia, New Zealand, Hong Kong, Singapore, Vietnam, SriLanka and Dubai has given him the exceptional opportunity to transform healthcare businesses in both developing and developed countries.

Vishal is currently Asia Head - Healthcare , TPG Growth which is amongst the leading private equity firms globally. He is also Co -founder & Chairman of Medwell Ventures, India.

Prior to his current assignment Vishal was the Group CEO for Fortis Healthcare Limited. His earlier roles also include CEO for Fortis Healthcare International in Singapore and CEO for Fortis Hospitals in India. His past assignment also includes spearheading the growth and transformation of Wockhardt Hospitals from a single hospital to one of India’s largest speciality hospital chains as its CEO & Managing Director. His expertise in integrating healthcare strategy with operations and management has set industry benchmarks. He sits on the board of leading healthcare organisations and has been an invited member of the Strategic Initiatives group of Joint Commission International, US and a past member of the Global Agenda Healthcare Council of the World Economic Forum. Vishal Co-Chairs Healthcare Services for Federation of Indian Chamber of Commerce and Industry.

V.Thiyagarajan is founder and CEO of Sybrant. His first home-away-from-home was Camac Software Founder CEO, a research & development outsourcing company focused on network products. His career started as a systems design engineer in the embedded systems space doing hardware and software design and was involved in large scale implementation of SCADA projects. He also had a consulting stint in technology and strategy for Fortune 500 companies in the insurance, telecom, financial services, logistics and industrial/building automation industries. In his last assignment, he was instrumental in creating a $32 Million outsourced product development company within a few years.

He is the initiator behind IHHC. The idea grew out of the pain of finding a home care nurse for the parents of a friend. This experience was the seed which evolved into IHHC.

India Value Fund Advisors (IVFA) was established in 1999 with a focus on investing in and transforming mid-sized profitable businesses into world-class industry leaders, built on the strong foundation of IVFA Values. Steered since its inception by Vishal Nevatia, IVFA has built deep knowledge and skills in the Indian markets and has successfully launched five separate investment funds with a combined corpus of over US$ 1.8 billion. Currently, IVFA is investing out of IVF - V, which has a corpus of US$ 682 million.

IVFA follows either ‘Buy and Build' or ‘Invest and Build' business model. In ‘Buy and Build’, IVFA acquires majority equity stakes, partners with high quality management teams and entrepreneurs to build scale and profitability. On the other hand, in ‘Invest and Build', IVFA acquires significant minority equity stakes and plays a supportive role to existing entrepreneurs in transforming businesses. Over 70% of all ca....More

Brand Capital is a part of Bennett, Coleman & Co. Ltd. (BCCL). We work with young businesses in creating iconic brands for our clients by putting the unmatched might of our media offerings along with our brand building expertise. At the core we engage with growth- oriented Indian entrepreneurs; established as well as new-gen; to provide funding for long- term advertisement solutions. To augment the core offering of Brand Capital as above, we have 3 more solutions offered - Brand Estate, SpringBoard & BrandScope.

Brand Estate helps to propel real-estate brands to top-of-mind by providing innovative brand-building solutions. Spring Board helps to propel Asset-light concepts into Super Brands through the infusion of high-decibel advertising. At BrandScope we create brands, positioned at different consumer segments with the ability to straddle multiple content, experience and product categories. Our aim is to help businesses targeting similar consumer segments to ride....More

With a dedicated and experienced team spread across offices in Chennai, Bangalore and Hyderabad, Veda brings a strong track-record in handling a variety of transactions.

Veda has successfully closed more than 85 transactions amounting to USD 3 Billion in value, across a spectrum of industries such as Healthcare, Technology, Real Estate, Infrastructure, Food/Agriculture, Consumer Services and Business Services.

In the healthcare space, Veda is amongst the top ranking investment banks having crafted close to 20 transactions across segments (Health care delivery - Multi specialty and Single Specialty hospital chains, Diagnostic Services, Medical technology and Contract research)

Cloudnine is India's premier birthing, woman and child care facility. Driven by the core objective of delivering world-class healthcare services in India, Cloudnine healthcare facilities herald the beginning of a new era for all women and child care needs.

Cloudnine was established in 2007. Since then, it has rapidly expanded and spread its wings across India. Currently, it has it’s presences in major metro cities like Bangalore, Chennai, Gurgaon, Pune & Mumbai and plans to expand into cities like Coimbatore, Mysore, Mangalore, Indore, Surat, Nagpur and Noida.

Cloudnine is the result of the founder and senior neonatologist Dr. R. Kishore Kumar's vision of bridging the ever-widening gap between Indian and international standards of healthcare.
Cloudnine provides world-class medical care, comprehensive services and an atmosphere of love, care and well-being. Its global best-in-class survival rate for neonates - 99.72% - is a remarkable achi....More

iGenetic is a research driven diagnostics company focusing on oncology, IVF and infectious diseases. The company has developed unique and hard-to-perform tests by leveraging its proprietary research. The company was incorporated in 2013 and commercially launched its operations in 2014. Its central processing lab based in Mumbai houses the entire value chain in pathology including Next Generation Sequencing. Currently the company has operations in Mumbai, Delhi, Hyderabad, Ahmedabad, Nagpur, Pune, Akola and many other cities. Its rapidly expanding footprint includes satellite labs and collection centers across several cities in India.

The company has the most compressive diagnostics offerings in the field of Oncology, infection & critical and gynecology & IVF streams. The scientific team is world class having experience across developed markets like US and UK and significant experience in Indian markets as well. The company has unique offerings like 24 hrs Sep....More

A group of highly skilled doctors observed that all major hospital chains has been focusing on metropolitan cities, and the district headquarters and towns in India have still remained untouched by the revolution of super specialty healthcare. In order to bridge this gap in reaching to tier-2 cities and district towns of North-India, the group in 2011, laid the foundation of Cygnus Hospitals, with the passion to bring accessible and finest quality healthcare at most affordable purchasing parity. Today, the group very proudly claim of successfully performing over 25,000 life-saving surgeries across 9 hospital locations with 5 in Haryana and 4 in Delhi, since its inception. With this success, the group now aims to expand to more geographical locations across north-India, and bringing positive changes in healthcare to 10 million lives.

In this short span of three years, Cygnus Hospitals has developed into 9 hospitals of super specialty medical excellence, with strength of 800....More

Veradis provides Investment Banking advisory services (M&A and PE fundraising) with a focus on Healthcare and Consumer sectors. Veradis has had significant depth of experience in these sectors, with expertise across all segments of Healthcare Delivery (hospitals, medical devices, diagnostics chains and single speciality centers) & Consumer Brands (apparel, accessories, foods and other retail brands).

The Veradis team comes from a diverse background with experience across Corporate Finance, Business Consulting & Strategy; and in the past have advised on multiple M&A and PE fundraising transactions for leading healthcare and consumer brand companies with total transaction value of over Rs 3000 crores.

Health Care at Home India is backed by the Burman family (the promoters of Dabur), with their proud legacy of trust and excellence for over 125 years. Our endeavour is also backed by the clinical credibility of the founders of the Health Care at Home UK, where the company has a healthy market share of 80% and is considered a leader and pioneer in home healthcare. In India, we look to bring significant value to the healthcare industry and the home health service sector by drawing synergies and lending support to existing organizations. Above all we aim to bring quality health care, offering comfort and convenience to the patient right at their door step.

Health Care at Home India is committed to:
• Deliver high quality clinical care to achieve the best possible outcome for patients.
• Deliver customers with services and protocols that go beyond just medical care.
• Provide a healthy and satisfying wor....More

Attune Technologies
We are a visionary healthcare information technology company that delivers next generation healthcare IT products to the market. While most of the other vendors focus on just implementing the software, we focus primarily on delivering business benefits to our customers.

We can boast of a Management team who have experience in managing the Technology solution for the World’s Largest Civilian IT Project - The CFH Program in UK. We also have the backing of one of the Premier Private Equity Players – Mercatus Capital. Our International presence also gives us the advantage of having worked across diverse cultures; this experience helps us to provide the necessary service quickly and efficiently.

Attune Health Kernel is a secure and completely state of the art web-based solution for hospitals that integrates all its departments and branches that are geographically separated. All the hospitals/branches needs are lo....More

SIX Swiss Exchange is the leading independent exchange in Europe and an ideal listing location for companies of every origin, size and sector. Listed companies benefit from access to experienced, highly capitalized international investors and high liquidity. Thanks to our excellent networking and personal support we offer them an efficient capital-raising. We maintain a close dialogue with both our domestic and foreign customers, working intensively with them to create optimal conditions for their success. www.six-swiss-exchange.com

Areté Advisors (the Firm, Areté) is a boutique management consulting firm offering advisory and new business incubation services. The Firm provides services across a wide range of services including Healthcare, Food and Agriculture, Construction, Logistics, Education, Infrastructure and others.

The Swiss Business Hub India (SBHI) is the official trade and investment arm of the Swiss federal government. The SBHI is headquartered within the the Consulate General of Switzerland in Mumbai with regional chapters within the Embassy of Switzerland in New Delhi and the Consulate General of Switzerland in Bengaluru.

The SBHI has two areas of focus, i.e.,

Advising Indian companies on investing in Switzerland: The SBHI advises Indian companies considering outbound greenfield investments in Europe in general and specifically in Switzerland. Our advisory services cover aspects relating to economic and legal environment, provisions and limitations of the different legal entities, company incorporation process, labour market and laws, cost structures, tax structures, allocating key functions such as R&D centres, trading/ sales/marketing offices, licenses/IPR structures and European/Global headquarters in Switzerland. Our focus sectors include life....More

Tata Capital Growth Fund ("TCGF"), a USD 225 million sector agnostic private equity fund was raised in 2011 with participation from global and Indian institutional investors. TCGF targeted investments in companies that derived a substantial portion of their revenues from operations in India. TCGF invested between US$10 million and US$35million across nine portfolio companies with significant minority stakes, and is substantially committed. TCGF successfully leverages the strengths of the wider Tata Group across all four facets of private equity, i.e. deal sourcing, deal evaluation, value add and exit.

TCGF invested in industry leading companies in the Financial services, IT & ITES, Healthcare services, Manufacturing and Pharmaceutical sector. As per Preqin, TCGF is ranked in the top quartile of PE funds focused on India with a 2011 vintage.

PlexusMD (www.plexusmd.com) is India's leading professional network for doctors and healthcare organisations. 60,000+ doctors across India use PlexusMD to stay updated, collaborate with peers and discover great opportunities. For healthcare organisations, PlexusMD is the fastest and most cost-effective means to engage with targeted doctor groups across India. Every week on PlexusMD, hundreds of cases and stories are read by 15,000+ doctors, hospitals receive applications from over 200 doctors and 300+ tickets are sold for academic programs across the country.

Healthcare Executive is an exclusive online Healthcare Business magazine based in India .It was born after Asia’s leading Healthcare Consultancy Establishment HOSMAC saw a demand for awareness of the Indian Healthcare Industry. A combination of years of expertise, gathering of best practices resulted in a need to address the dearth of information available to help Healthcare industry leaders take decisions today. Healthcare Executive is aiming to empower the Executives of the Indian healthcare Industry with credible information to help them steer their organisations better. The Magazine intends to be the exclusive healthcare resource guide for healthcare ideas, design,strategies, technology and practice for Healthcare executives creating, leading, and transforming the Healthcare Scenario in India.

Indian Angel Network, India's first and largest angel network, brings together successful entrepreneurs and CEOs who share a passion to enable more early stage businesses to create scale and value. By focusing on startups, the Network addresses the current acute lack of funds available to early stage companies. The Network believes that early stage businesses require more than just money to succeed. They require close mentoring and inputs on strategy as well as execution.

Indian Angel Network currently has over 300 members drawn from across the country and some from overseas, comprising the who's who of successful Indian entrepreneurs and CEOs from diverse sectors (information on www.indianangelnetwork.com). The Network has met with early success and has already invested in 100 portfolio companies including investee and incubatee companies. IAN has become the hub for innovative ventures founded by high quality entrepreneurs seeking mentoring an....More

Our online portal www.medicards.in launched in 2007 is a step towards achieving our Vision to provide information which is valuable to everyone in the Indian Healthcare Industry. Another of our ventures is the print edition of our portal the MEDICARDS RESOURCE GUIDE DIRECTORY which is an effort to help the Doctor/ Administrator or a Purchase Manager to get source information far more easily , rather than search through bundles of catalogues/brochures and Business Card Folders.

The First edition of MediCards Resource Guide in print was launched in November 2010 contains list of 30+ categories, 1000+ Products / Services, 3000+ Brands/Models, 3000+ Vendors, 200+ Conferences/ Events, 100+ Associations. The Guide is designed in such a way , that the information has been categorized Specialty wise , Product/Services wise and Vendor wise in the Alphabetical order to facilitate faster search

“The Indus Entrepreneurs (TiE) Pune: A non-profit global network of entrepreneurs and professionals, established to foster entrepreneurship and nurture entrepreneurs.

Fosters entrepreneurship globally through Mentoring, Inspiration, Networking, and Education. Dedicated to the virtuous cycle of wealth creation and giving back to the community, TiE Pune’s focus is on generating and nurturing our next generation of entrepreneurs. TiE Pune hosts a wide range of programs and events, including TiECon Pune, (www.tieconpune.org) the largest professional and networking conference for entrepreneurs. www.pune.tie.org

Health Biz India was started as India’s 1st Online monthly B2B (Business to Business) magazine for the medical and healthcare industry. It focuses on the latest developments in the health care delivery, services, equipment and technology segment. It also focuses on hospitals and other allied medical services. In summation, it provides tangible and constructive information to the medical fraternity and strives to serve as a platform for the entire medical industry and its allied sectors at large, your window to the world of the medical and health sector.

Broadly, Health Biz India can be viewed as:

• A B2B magazine focused on the medical and health care equipment and technology industry. A magazine for hospitals, clinics, pathology labs, nursing homes and doctors. A sourcebook that facilitates almost all buying decisions of the medical fraternity
• An interactive platform and voice of....More

“Bi- Monthly Magazine” MEDGATE TODAY, is India’s most comprehensive, well researched, informative & Extensive coverage Magazine published by Advance Media Group. India’s largest circulated Bi -Monthly magazine on Health and Medical.”Medgate Today” has a wealth of intelligent and up-to-date information spanning the entire gamut of Health & Medical world. Medgate Today ensures to advertisers as it delivers an audience, doctors, and hospitals, Surgeons who is involved in entire process of decision-making.

TLabs is the leading technology accelerator in India that operates a 4 month program, twice a year, with 60+ mentors supporting the companies that become part of it. With 6 Batches and 36 companies, TLabs has seen a tremendous success rate with over 65% of the companies getting funded raising over $200k investments per team. Startups that go through the program get intensive mentoring from in-house and external mentors to shape ideas into viable businesses.

Mumbai Angels, started in 2006 is the first premium Angel network in India. The Mumbai Angels provides a unique platform to start up and very early stage companies by bringing them face to face with successful entrepreneurs, professionals and executives who are interested in and have the funds available to invest in start-up companies. Many members of Mumbai Angels have prior Silicon Valley experience. In addition to the capital of its members, the Mumbai Angels provides access to high quality mentoring, vast networks in India and abroad and inputs on strategy as well as execution.

Mumbai Angels provides its portfolio companies with a level of assistance that surpasses their highest expectations. Mumbai Angels network of relationships and their ability to leverage those relationships on behalf of their portfolio companies is unparalleled. Mumbai Angles members and their organisations have come to represent the ideal business partner for entrepreneurs who wish to start and....More

AI-MED is an Umbrella Association of Indian Manufacturers of Medical Devices covering all types of Medical Devices including consumables, disposables, equipments instruments and diagnostics. With a Primary Membership of over 300 Manufacturers and additionally of over 200 Associate Members representing the interest of over 700 Manufacturers of Medical Devices to address the manufacturer’s problems. (www.aimedindia.com)

The aim behind forming AI-MED is allow the Indian Government to access a single point of contact and provide various services to the manufacturers like Advocacy on policy issues, Information services, Regulations for medical devices, Education and Training, services, Testing Assistance and guidance for Quality Certification (ISO, CE, GMP), Lobbying for funding for R&D from the Government, encourage innovations from member units, Improve clinician and patient....More

TiE (The Indus Entrepreneurs) Mumbai is one of the most vibrant and fastest growing entrepreneurial ecosystems in the TiE Network, the world’s largest non-profit global network of entrepreneurs and professionals dedicated to the advancement of entrepreneurship. TiE Mumbai currently works towards growing and supporting the entrepreneurial community across various sectors, some of them as mentioned below:

TiE Food Network (TFN) is an initiative towards encouraging and supporting entrepreneurship in the foodspace, by providing entrepreneurs with a platform where they can network, learn and get mentored.

​Media and Entertainment Network by TiE (MENT) works towards enabling and empowering entrepreneurs in the media & entertainment industry across Mumbai & Pune. It aims to provide a platform for entrepreneurs, founders and CXOs in the industry to interact with peers, solve common founder challenges and facilitate curated networking.

Drug Today Medical Times (DTMT) is the leading newspaper devoted to the Health Sector, published from New Delhi, India, under the aegis of Drug Today, which has, since its inception in the year 1993, been South Asia’s most comprehensive and most-trusted medical publication. Being a vibrant newspaper, medical professionals across the country identify with DTMT. DTMT is a complete health newspaper which is bringing healthcare issue out of the closet. Brought out by a core group of healthcare professionals, the newspaper has worked as a catalyst to usher in change for the better in this industry.

DTMT provides accurate information and reporting on the latest development in the field of health and hygiene and keeps the readers abreast with the latest research across the world. Doctors and healthcare professionals across South Asia find DTMT to be of value in their day-to-day work, which is why they preserve even past copies of this publication.

ehealth magazine has a widespread reach across health verticles in the country. The magazine's pan India presence helps to formulate connections with the hospitals from all regions and establish close relationship with the government bodies. We do extensive research while doing stories, news and health features. We have also touched upon various segments from startups to the corporates. Our eHealth portal stands on the 2009th position in ALEXA ranking.

Standard Fees:
INR 12000 + Service tax per attendee

Special Discount Offer available for Healthcare Start ups for limited period. Please get in touch with Kanika / Shikhil to avail the offer.
Email: register@vccircle.com
Ph: 0120 4171111

For Any Queries:
Write to register@vccircle.com
*The registration fee does not include any travel, accommodations or other costs incurred by attendees.

Cancellation Policy:
There is no cash refund in case you cancel the registration from your end. We will issue a credit note for an equivalent amount which you can adjust/utilise against any of our future events (under the validity period) if the registration is cancelled at least 3 days before the event, post which NO credit note will be issued. Please talk to Kanika / Shikhil for further details.

If the event is cancelled from our end due to any circumstances, we will refund the registration amount.

Substitution Policy:
Substitutions within a company are permitted through the conference date. Shared registrations are not permitted under any circumstances.